Back

Erythrocyte-targeted immunomodulatory antigens enabled by in vivo selection of D-peptides

Loftis, A. R.; Zhang, G.; Backlund, C.; Quartararo, A. J.; Pishesha, N.; Schissel, C. K.; Garafola, D.; Loas, A.; Collier, R. J.; Ploegh, H.; Irvine, D. J.; Pentelute, B. L.

2020-07-15 bioengineering
10.1101/2020.07.15.203331 bioRxiv
Show abstract

Targeting of antigens to erythrocytes can be used to selectively mitigate their immunogenicity, but the methods to equip a variety of cargoes with erythrocyte-targeting properties are limited. Here we identified a D-peptide that targets murine erythrocytes and decreases anti-drug antibody responses when conjugated to the protective antigen from Bacillus anthracis, a protein of therapeutic interest. The D-peptide likewise decreases inflammatory anti-ovalbumin (OVA) CD8+ T cell responses when attached to a peptide antigen derived from OVA. To discover this targeting ligand, we leveraged mass spectrometry to decode a randomized D-peptide library selected in mice, extending the application of synthetic libraries to in vivo affinity selections.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.